Antiplatelet Therapy for ACS Patients in the Outpatient Setting: Lessons from the 2010 CCS Guidelines – MOC Section 3

Describe the impact of antiplatelet therapy on risk reduction post ACS
Communicate the recommendations of the 2010 CCS antiplatelet guidelines with respect to antiplatelet therapy post ACS
Discuss the efficacy and safety of the various antiplatelet agents recommended in the CCS antiplatelet guidelines
Distinguish between the requirements for patients with medically managed ACS compared to those who are managed with PCI
Discuss the implications for therapy of a patient with a bare metal stent compared to a patient with a drug-eluting stent